As with any post about medications pertaining to celiac disease, I want to start this one off with some managed expectations: the research contained in the next few paragraphs is promising, but don’t go out and buy yourself a croissantwich just yet.
But: there is research! And it is promising! Eventually, one of these years, probably, we will have a whole host of options for how we choose to interact with gluten. Today’s exciting research tidbit comes out of Israel, where a company called BioLineRx has announced pre-clinical results of a drug that reduces the toxicity of gluten for people with celiac disease.
Click to continue reading »